Curreio and Iktos Announce Collaboration in New Drug Discovery
Tokyo, Japan, 06, 08, 2023 – Curreio, Inc. (Curreio), a Japanese company specializing in structural analysis of biomolecules using cryo-electron microscopy, and Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration agreement in AI for new drug design. In this collaboration, Curreio’s state-of-the-art cryo-EM platform in combination with Iktos’ de […]